Stephen D. Rubin

8.7k citations
17 papers · 4.0k indexed · 1 hit paper · h-index 13

Impact in

  • Oncology top 1%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • HER2/EGFR in Cancer Research 6
    • Cancer Treatment and Pharmacology 3
    • Colorectal Cancer Treatments and Studies 2
    • Pancreatic and Hepatic Oncology Research 2

Stephen D. Rubin

17 papers receiving 3.9k citations

Hit Papers

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer 2006 · 2.5k citations
2.5k200620262012201950010001.5k2.0k

Peers

Stephen D. Rubin
Comparison fields: 5 of 104
  • Oncology 2.6k
  • Cancer Research 673
  • Pulmonary and Respiratory Medicine 1.3k
  • Genetics 413
  • Radiology, Nuclear Medicine and Imaging 811
Replace Drew Rasco with:
Drew Rasco United States
Allen Lee Cohn United States
Andréa Varga France
Gilles Romieu France
Ulrik Lassen Denmark
Erika Hamilton United States
Florence Dalenc France
Richard A. Messmann United States
Scott N. Holden United States
Begoña Mellado Spain
Stephen D. Rubin relative to Drew Rasco United States Drew Rasco's profile →
Citations per field
00.5×2.7×
Drew Rasco · 1×
Citations per year

Countries citing papers authored by Stephen D. Rubin

Since Specialization
Citations

This map shows the geographic impact of Stephen D. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Rubin more than expected).

Fields of papers citing papers by Stephen D. Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Rubin. The network helps show where Stephen D. Rubin may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen D. Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen D. Rubin Line = papers co-authored together Stephen D. Rubin links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 2018237
2 20145
3 2013349
4 201250
5 201225
6 20123
7 20121
8 2011160
9 2011126
10 200841
11
Lapatinib prevents the metastatic colonization of EGFR+ and Her-2+ breast cancer cells in the brain.
20074
12
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Hit paper breakdown →
20062498
13 2005160
14 200537
15 200479
16 2004106
17 200378

About Stephen D. Rubin

Stephen D. Rubin is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Dermatology, having authored 17 papers that have together received 4.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (5 papers), Renal cell carcinoma treatment (3 papers), Brain Metastases and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers), Renal and related cancers (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (673 citations), Pulmonary and Respiratory Medicine (1.3k citations), Genetics (413 citations) and Radiology, Nuclear Medicine and Imaging (811 citations). Stephen D. Rubin has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Mario Campone, Bella Kaufman, Charles E. Geyer, David Cameron, Agnieszka Jagiełło-Gruszfeld, Cristina Oliva, Stephen Chan, Tadeusz Pieńkowski, Neville Davidson and Dimosthenis Skarlos. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism, Pharmaceutical Research, Clinical Cancer Research and The Journal of Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026